Morin et al. (2013)

Summary of novel genes

Entity Tier 1 genes Tier 2 genes
DLBCL 9 29
--- config: sankey: showValues: true linkColor: target width: 600 height: 300 nodeAlignment: right prefix: '(' suffix: ' genes)' --- sankey-beta This study, New Tier 1, 9 New Tier 1, DLBCL Tier 1, 9 This study, New Tier 2, 29 New Tier 2, DLBCL Tier 2, 29 All other DLBCL studies, DLBCL Tier 1, 118 All other DLBCL studies, DLBCL Tier 2, 186

Novel genes reported in this study

Tier 1

New gene DLBCL tier
CD83 1
CDKN2A 1
GNAI2 1
HIST1H1D 1
HIST1H2AC 1
IKZF3 1
MPEG1 1
RB1 1
TAF1 1

Tier 2

Novel Gene DLBCL Tier Average variant quality QC outcome
ABI3BP 2 ★ ★ ★ ☆ ☆ Pass
CDH9 2 ★ ★ ★ ☆ ☆ Pass
CNTNAP5 2 ★ ★ ★ ★ ☆ Pass
DNAH5 2 ★ ★ ★ ★ ☆ Pass
DSG4 2 ★ ★ ★ ☆ ☆ Pass
FAT4 2 ★ ★ ★ ☆ ☆ Pass
HDAC7 2 ★ ★ ★ ☆ ☆ Pass
HIST1H2AG 2 ★ ★ ★ ☆ ☆ Pass
IFNGR1 2 ★ ★ ★ ★ ☆ Pass
LRRN3 2 ★ ★ ★ ★ ★ Pass
MPDZ 2 ★ ★ ★ ★ ☆ Pass
NLRP5 2 ★ ★ ★ ☆ ☆ Pass
ODZ3 2 ★ ★ ★ ☆ ☆ Pass
P2RX5 2 ★ ★ ★ ☆ ☆ Pass
PASK 2 ★ ★ ★ ★ ☆ Pass
PCDHB11 2
PDS5B 2
PKD1 2
POGZ 2
PRKCB 2
PTPN23 2
SAMD9L 2
SARM1 2
SRRM2 2
SYPL1 2
WDFY3 2
IER2 2 ★ ☆ ☆ ☆ ☆ Fail
FAM38B 2 ★ ★ ☆ ☆ ☆ Fail
FNDC1 2 ★ ★ ☆ ☆ ☆ Fail

Details

Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall, Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and Structural Analysis of Diffuse Large B-cell Lymphoma Using Whole-Genome Sequencing.” Blood 122 (7): 1256–65. https://doi.org/10.1182/blood-2013-02-483727.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.